273 related articles for article (PubMed ID: 22891699)
1. Differences in the acute pulmonary vascular effects of oxygen with nitric oxide and diltiazem: implications for the long-term treatment of pulmonary arterial hypertension.
Day RW
Congenit Heart Dis; 2013; 8(1):71-7. PubMed ID: 22891699
[TBL] [Abstract][Full Text] [Related]
2. Acute Pulmonary Vasodilator Testing and Long-Term Clinical Course in Segmental Pulmonary Vascular Disease.
Domingo L; Magdo HS; Day RW
Pediatr Cardiol; 2018 Mar; 39(3):501-508. PubMed ID: 29196781
[TBL] [Abstract][Full Text] [Related]
3. Effects of inhaled nitric oxide in patients with hypoxemia and pulmonary hypertension after cardiac surgery.
Bender KA; Alexander JA; Enos JM; Skimming JW
Am J Crit Care; 1997 Mar; 6(2):127-31. PubMed ID: 9172849
[TBL] [Abstract][Full Text] [Related]
4. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.
Sitbon O; Humbert M; Jaïs X; Ioos V; Hamid AM; Provencher S; Garcia G; Parent F; Hervé P; Simonneau G
Circulation; 2005 Jun; 111(23):3105-11. PubMed ID: 15939821
[TBL] [Abstract][Full Text] [Related]
5. Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.
Sitbon O; Humbert M; Jagot JL; Taravella O; Fartoukh M; Parent F; Herve P; Simonneau G
Eur Respir J; 1998 Aug; 12(2):265-70. PubMed ID: 9727772
[TBL] [Abstract][Full Text] [Related]
6. [Precapillary pulmonary hypertension of uncertain etiology].
Halank M; Wiemer M; Tschöpe C; Poller W; Schwimmbeck P; Horstkotte D; Höffken G
Dtsch Med Wochenschr; 1998 Jul; 123(28-29):861-5. PubMed ID: 9693656
[TBL] [Abstract][Full Text] [Related]
7. Inhaled nitric oxide for the adult respiratory distress syndrome.
Rossaint R; Falke KJ; López F; Slama K; Pison U; Zapol WM
N Engl J Med; 1993 Feb; 328(6):399-405. PubMed ID: 8357359
[TBL] [Abstract][Full Text] [Related]
8. Calcium-channel blockers in pulmonary arterial hypertension.
Chaumais MC; Macari EA; Sitbon O
Handb Exp Pharmacol; 2013; 218():161-75. PubMed ID: 24092340
[TBL] [Abstract][Full Text] [Related]
9. Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry.
Douwes JM; Humpl T; Bonnet D; Beghetti M; Ivy DD; Berger RM;
J Am Coll Cardiol; 2016 Mar; 67(11):1312-23. PubMed ID: 26988953
[TBL] [Abstract][Full Text] [Related]
10. [Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to pulmonary fibrosis].
Olschewski H; Ghofrani HA; Walmrath D; Schermuly R; Temmesfeld-Wollbrück B; Grimminger F; Seeger W
Pneumologie; 2000 Mar; 54(3):133-42. PubMed ID: 10783653
[TBL] [Abstract][Full Text] [Related]
11. Soluble guanylate cyclase activator reverses acute pulmonary hypertension and augments the pulmonary vasodilator response to inhaled nitric oxide in awake lambs.
Evgenov OV; Ichinose F; Evgenov NV; Gnoth MJ; Falkowski GE; Chang Y; Bloch KD; Zapol WM
Circulation; 2004 Oct; 110(15):2253-9. PubMed ID: 15466650
[TBL] [Abstract][Full Text] [Related]
12. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance.
Kieler-Jensen N; Ricksten SE; Stenqvist O; Bergh CH; Lindelöv B; Wennmalm A; Waagstein F; Lundin S
J Heart Lung Transplant; 1994; 13(3):366-75. PubMed ID: 8061011
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide, oxygen, and prostacyclin in children with pulmonary hypertension.
Turanlahti MI; Laitinen PO; Sarna SJ; Pesonen E
Heart; 1998 Feb; 79(2):169-74. PubMed ID: 9538311
[TBL] [Abstract][Full Text] [Related]
15. [Favorable response of pulmonary hypertension in patients with chronic obstructive airway disease treated with diltiazem].
Gassner A
Schweiz Med Wochenschr; 1984 Mar; 114(10):332-7. PubMed ID: 6710104
[TBL] [Abstract][Full Text] [Related]
16. Low doses of inhaled nitric oxide in heart transplant recipients.
Auler Júnior JO; Carmona MJ; Bocchi EA; Bacal F; Fiorelli AI; Stolf NA; Jatene AD
J Heart Lung Transplant; 1996 May; 15(5):443-50. PubMed ID: 8771498
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide in the evaluation of congenital heart disease with pulmonary hypertension: factors related to nitric oxide response.
Cannon BC; Feltes TF; Fraley JK; Grifka RG; Riddle EM; Kovalchin JP
Pediatr Cardiol; 2005; 26(5):565-9. PubMed ID: 16132310
[TBL] [Abstract][Full Text] [Related]
18. [Effect of diltiazem on lipid profiles and heart rate in hypertensive patients].
Carré A; Joire JE; Mounier-Vehier C; Lequeuche B
Ann Cardiol Angeiol (Paris); 1999 Mar; 48(3):221-6. PubMed ID: 12555384
[TBL] [Abstract][Full Text] [Related]
19. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension.
Curran RD; Mavroudis C; Backer CL; Sautel M; Zales VR; Wessel DL
Ann Thorac Surg; 1995 Dec; 60(6):1765-71. PubMed ID: 8787478
[TBL] [Abstract][Full Text] [Related]
20. Acute vasodilator test in pulmonary arterial hypertension: evaluation of two response criteria.
Costa EL; Jardim C; Bogossian HB; Amato MB; Carvalho CR; Souza R
Vascul Pharmacol; 2005 Sep; 43(3):143-7. PubMed ID: 16061423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
